The effect of depolarizing relaxants on the neuromuscular refractory period of anesthetized man.
D000200:Action Potentials; D000769:Anesthesia, Inhalation; D003650:Decamethonium Compounds / Q000008:administration & dosage / Q000494:pharmacology; D004558:Electric Stimulation; D004576:Electromyography; D005449:Fluorenes / Q000008:administration & dosage / Q000494:pharmacology; D006221:Halothane; D006801:Humans; D007275:Injections, Intravenous; D009431:Neural Conduction / Q000187:drug effects*; D009467:Neuromuscular Depolarizing Agents / Q000494:pharmacology*; D009469:Neuromuscular Junction / Q000187:drug effects*; D009609:Nitrous Oxide; D000644:Quaternary Ammonium Compounds / Q000008:administration & dosage / Q000494:pharmacology; D012032:Refractory Period, Electrophysiological / Q000187:drug effects; D013390:Succinylcholine / Q000008:administration & dosage / Q000494:pharmacology; D014459:Ulnar Nerve / Q000187:drug effects / Q000502:physiology
D003650:Decamethonium Compounds; D005449:Fluorenes; D009467:Neuromuscular Depolarizing Agents; D000644:Quaternary Ammonium Compounds; D013390:Succinylcholine; D009609:Nitrous Oxide; D006221:Halothane